Article
A UGT2B17‐positive donor is a risk factor for higher transplant‐related mortality and lower survival after bone marrow transplantation
1 Apr 2005
Abstract excerpt
We recently identified a human minor histocompatibility (H) antigen, encoded by UDP glycosyltransferase 2 family, polypeptide B17 (UGT2B17), whose immunogenicity results from differential expression in donor and recipient cells as a consequence of a homozygous deletion of the UGT2B17 gene. UGT2B17 is highly expressed in the liver and colon, which are major targets for graft-versus-host disease (GVHD). To assess...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
